Character Bio lands $93M for 2 trials in dry AMD

The latest stories trending on MedCity News.

Editor's Pick

Top Story Seeing a Better Way for Eye Drug R&D, Character Bio Lands $93M for Two Trials in Dry AMD Apellis Pharmaceuticals and Astellas Pharma have the first two FDA-approved therapies for geographic atrophy, but Character Biosciences claims its approach could be best in class for treating this advanced form of dry age-related macular degeneration. The biotech's Series B round will finance clinical tests of two programs, each addressing a different stage of the disease. Sponsored How to Improve Employee Benefits While Reducing Insurance Costs Presented by The Difference Card Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost. Learn more. Stephen Smith, Co-Founder & CEO of NOCD will be Speaking at INVEST 2025! Stephen will be part of the panel, "Here's How We Found Our Healthcare AI Champion".  In this panel a startup founder/CEO will do a 10-minute presentation that explains how the startup was able to find a champion within a healthcare organization that led to a successful deployment. This will be followed by a Q&A with the startup presenter and the Champion – either a doctor, provider lead, life sciences lead, payer lead or employer lead. Register For INVEST Chicago Now

Featured News

Navina Snags $55M for Its Value-Based Care AI Copilot Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models. Wisp Unveils Male Bacterial Vaginosis Partner Treatment Following evidence showing that bacterial vaginosis affects both men and women, Wisp has launched a male BV partner treatment. What Healthcare Workers Need Now to Improve Their Wellbeing For all the talk about this problem, the industry has struggled to make big headway. But there are solutions — here are a few steps that make a substantial difference. Continuous Process Improvement: The Secret to Navigating Early-Phase Drug Development  Deploying a robust continuous improvement methodology is especially beneficial in the earliest phases of drug development. It can help ensure the delivery of high-quality, reliable, timely bioanalytical and clinical data to make informed decisions about either moving on to the next drug development milestone or pivoting to another strategy.

Video   23andMe Files for Bankruptcy: How to Delete your Data 23andMe filed for bankruptcy on Sunday following years of decreased demand for its genetic testing product. Former users are rushing to delete their data from the company's platform — which is a task that may require some patience.

Sponsored Everything You Need to Know About Sterilization Cases and Their Role in Healthcare Presented by Jewel Precision Innovative sterilization cases and trays are instrumental in reducing infection risk in medical settings. Learn notable things about them and their makers. Learn More

Resources

Debunked Episode 13: Will the Real AI Please Stand Up? The latest episode of Debunked, with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, talked about the many iterations of AI, NIH funding cuts, and a deal to sell Walgreens. Watch Now!

MedCity News • PO Box 901 • New York, NY unsubscribe